Following this operation, Verso Capital and its co-shareholder will hold 5,505,397 shares, representing 26,40% of the share ...

The preliminary consolidated results cover the period from April 1, 2024, to September 30, 2024. CBI announces the activation of a share buyback plan with a maximum price per share of €0.50 and a ...

Exeltis will be granted an exclusive license to market and distribute Theranexus' novel formulation TX01 for the treatment of ...

Iris Financial S.A. – Fulfilment Regulatory Approval Conditions Combination ...

HYMPULSION ORDERS 4 NEW HRS STATIONS AS PART OF THE HYDROGEN MOBILITY PROGRAM 'ZERO EMISSION VALLEY' IN THE ...

Communiqué de la société PAREF du 20/12/2024 - PAREF ASSISTED PARKWAY LIFE REIT IN THE ACQUISITION AND MANAGEMENT OF ITS ...

Following the audit procedures, the Group is publishing its full-year results in accordance with IFRS 5, with the ...

Lyon, France – 17 December 2024, 6.15 pm CET – Theranexus, a biopharmaceutical company innovating in the treatment of rare ...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT ...

In accordance with paragraph 9.6.14R of the Listing Rules of the Financial Conduct Authority, Renewi plc announces that on 19 December 2024, Non-Executive Director, Neil Hartley, was appointed as an ...

December 23, 2024 – VusionGroup (VU – FR0010282822) the global leader in digitalization solutions for commerce, today announced having signed a contract extension to accelerate the deployment of its ...